Rhizomelic PseudopolyarthritisSymptoms, Doctors, Treatments, Advances & More
Learn About Rhizomelic Pseudopolyarthritis
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
Bassett Medical Center
. Dr. Griger is rated as a Distinguished provider by MediFind in the treatment of Rhizomelic Pseudopolyarthritis. He is also highly rated in 18 other conditions, according to our data. His clinical expertise encompasses Paget's Disease of Bone, Rheumatoid Arthritis (RA), Polymyalgia Rheumatica, and Rhizomelic Pseudopolyarthritis.
Miguel Gay-Gonzalez practices practicing medicine in Santander And Univ. Of The Witwatersrand, South Africa. Mr. Gay-Gonzalez is rated as an Elite expert by MediFind in the treatment of Rhizomelic Pseudopolyarthritis. He is also highly rated in 57 other conditions, according to our data. His clinical expertise encompasses Vasculitis, Temporal Arteritis, Giant Cell Arteritis (GCA), Lung Transplant, and Kidney Transplant.
Mayo Clinic-Rochester
Eric Matteson is a Rheumatologist practicing medicine in Virginia Beach, Virginia. Dr. Matteson is rated as an Elite provider by MediFind in the treatment of Rhizomelic Pseudopolyarthritis. He is also highly rated in 19 other conditions, according to our data. His clinical expertise encompasses Rhizomelic Pseudopolyarthritis, Polymyalgia Rheumatica, Temporal Arteritis, Giant Cell Arteritis (GCA), and Tissue Biopsy.
Summary: To understand the severity and nature of participants experiences during irAEs following immune checkpoint inhibitor immunotherapy.
Summary: The pathophysiology of certain inflammatory arthritides remains poorly understood, particularly when associated with rare systemic autoimmune diseases such as systemic sclerosis (SSc), or when emerging in the context of immune-related adverse events from cancer immunotherapies. These immunotherapy-induced arthritides represent a new and increasingly encountered clinical entity in rheumatology. A d...